Anita Kumar
Indian Institute of Technology Hyderabad
ORCID: 0000-0002-4791-8199Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 3 papers. Top paper: βZanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trialβ.
Anthony R Mato, Ahmet Dogan, Venkatraman E Seshan, Erel Joffe, Kelsey Flaherty +41 more
Bassam Dahman, Christine R. Isaacs, Anita Kumar, Jordan Hylton, Sarah Conrad
Bassam Dahman, Anita Kumar, Jordan Hylton, Christine R. Isaacs, Sarah Conrad